Novartis receives EU approval for Jakavi ®, the first targeted therapy approved for patients with the rare blood cancer polycythemia vera
18 March 2015 | By Victoria White
Novartis announce that the EU has approved Jakavi ® for the treatment of adult patients with polycythemia vera (PV)...